SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-006035
Filing Date
2020-04-08
Accepted
2020-04-08 06:21:11
Documents
8
Period of Report
2020-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 43364
2 ex4-1.htm EX-4.1 118211
3 ex10-1.htm EX-10.1 214035
4 ex99-1.htm EX-99.1 68849
5 ex99-2.htm EX-99.2 13529
6 ex99-1_001.jpg GRAPHIC 8052
7 ex99-1_002.jpg GRAPHIC 4897
8 ex99-2_001.jpg GRAPHIC 6774
  Complete submission text file 0001493152-20-006035.txt   486780
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 20781058
SIC: 2835 In Vitro & In Vivo Diagnostic Substances